PortfoliosLab logoPortfoliosLab logo
MPWR vs. KNSA
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

MPWR vs. KNSA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Monolithic Power Systems, Inc. (MPWR) and Kiniksa Pharmaceuticals, Ltd. (KNSA). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, MPWR achieves a 57.89% return, which is significantly lower than KNSA's 80.22% return.


MPWR

1D
8.35%
1M
7.08%
6M
27.30%
YTD
57.89%
1Y
101.90%
3Y*
38.39%
5Y*
26.91%
10Y*
36.06%
ALL TIME*
27.19%

KNSA

1D
-4.94%
1M
18.22%
6M
69.26%
YTD
80.22%
1Y
145.67%
3Y*
57.85%
5Y*
37.13%
10Y*
ALL TIME*
14.55%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$68.75M$54.52M$46.86M
$1.37B$1.27B$1.35B

MPWR vs. KNSA - Yearly Performance Comparison


2026 (YTD)20252024202320222021202020192018
MPWR
Monolithic Power Systems, Inc.
57.89%54.45%-5.55%79.78%-27.78%35.49%107.49%54.80%-10.42%
KNSA
Kiniksa Pharmaceuticals, Ltd.
80.22%108.54%12.77%17.09%27.27%-33.39%59.76%-60.63%14.89%

Correlation

The correlation between MPWR and KNSA is 0.04, meaning there was essentially no consistent relationship between their historical price movements. Each responded to its own set of market drivers.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.04

Correlation (3Y)
Balances recent behavior with more history.

0.13

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.20

Correlation (All Time)
Calculated using the full available price history since May 24, 2018

0.22

The correlation between MPWR and KNSA shifts across timeframes, from 0.04 (1 year) to 0.22 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

MPWR:

$70.06B

KNSA:

$5.67B

EPS

MPWR:

$16.33

KNSA:

$1.00

PE Ratio

MPWR:

87.33

KNSA:

74.38

PEG Ratio

MPWR:

1.10

KNSA:

0.72

PS Ratio

MPWR:

21.32

KNSA:

7.14

PB Ratio

MPWR:

18.03

KNSA:

9.48

Total Revenue (TTM)

MPWR:

$3.27B

KNSA:

$840.85M

Gross Profit (TTM)

MPWR:

$1.81B

KNSA:

$546.22M

EBITDA (TTM)

MPWR:

$1.01B

KNSA:

$111.62M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

MPWR vs. KNSA — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

MPWR
MPWR Risk / Return Rank: 8989
Overall Rank
MPWR Sharpe Ratio Rank: 9191
Sharpe Ratio Rank
MPWR Sortino Ratio Rank: 8686
Sortino Ratio Rank
MPWR Omega Ratio Rank: 8484
Omega Ratio Rank
MPWR Calmar Ratio Rank: 9292
Calmar Ratio Rank
MPWR Martin Ratio Rank: 9090
Martin Ratio Rank

KNSA
KNSA Risk / Return Rank: 9797
Overall Rank
KNSA Sharpe Ratio Rank: 9797
Sharpe Ratio Rank
KNSA Sortino Ratio Rank: 9797
Sortino Ratio Rank
KNSA Omega Ratio Rank: 9696
Omega Ratio Rank
KNSA Calmar Ratio Rank: 9797
Calmar Ratio Rank
KNSA Martin Ratio Rank: 9898
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

MPWR vs. KNSA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Monolithic Power Systems, Inc. (MPWR) and Kiniksa Pharmaceuticals, Ltd. (KNSA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


MPWRKNSADifference
Sharpe ratioReturn per unit of total volatility

-1.05

Sortino ratioReturn per unit of downside risk

-1.75

Omega ratioGain probability vs. loss probability

1.30

1.52

-0.22

Calmar ratioReturn relative to maximum drawdown

3.94

6.94

-3.00

Martin ratioReturn relative to average drawdown

9.44

24.13

-14.68

MPWR vs. KNSA - Sharpe Ratio Comparison

The current MPWR Sharpe Ratio is 1.90, which is lower than the KNSA Sharpe Ratio of 2.94. The chart below compares the historical Sharpe Ratios of MPWR and KNSA, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

MPWR vs. KNSA - Drawdown Comparison

The maximum MPWR drawdown since its inception was -72.27%, smaller than the maximum KNSA drawdown of -83.06%. Use the drawdown chart below to compare losses from any high point for MPWR and KNSA.


Loading charts...

Drawdown Indicators


MPWRKNSADifference

Max Drawdown

Largest peak-to-trough decline

-72.27%

-83.06%

+10.79%

Max Drawdown (1Y)

Largest decline over 1 year

-25.99%

-21.12%

-4.87%

Max Drawdown (3Y)

Largest decline over 3 years

-51.65%

-34.14%

-17.51%

Max Drawdown (5Y)

Largest decline over 5 years

-51.65%

-53.17%

+1.52%

Max Drawdown (10Y)

Largest decline over 10 years

-51.65%

Current Drawdown

Current decline from peak

-15.49%

-8.13%

-7.36%

Average Drawdown

Average peak-to-trough decline

-17.71%

-40.09%

+22.38%

Ulcer Index

Depth and duration of drawdowns from previous peaks

10.83%

6.06%

+4.77%

Volatility

MPWR vs. KNSA - Volatility Comparison

The current volatility for Monolithic Power Systems, Inc. (MPWR) is 18.57%, while Kiniksa Pharmaceuticals, Ltd. (KNSA) has a volatility of 26.47%. This indicates that MPWR experiences smaller price fluctuations and is considered to be less risky than KNSA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


MPWRKNSADifference

Volatility (1M)

Calculated over the trailing 1-month period

18.57%

26.47%

-7.90%

Volatility (6M)

Calculated over the trailing 6-month period

44.07%

41.55%

+2.52%

Volatility (1Y)

Calculated over the trailing 1-year period

54.05%

49.77%

+4.28%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

54.63%

54.77%

-0.14%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

47.86%

64.34%

-16.48%

Dividends

MPWR vs. KNSA - Dividend Comparison

MPWR's dividend yield for the trailing twelve months is around 0.50%, while KNSA has not paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
KNSA
Kiniksa Pharmaceuticals, Ltd.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
MPWR
Monolithic Power Systems, Inc.
0.50%0.69%0.85%0.63%0.85%0.49%0.55%0.90%1.03%0.71%0.98%1.26%

Financials

MPWR vs. KNSA - Financials Comparison

This section allows you to compare key financial metrics between Monolithic Power Systems, Inc. and Kiniksa Pharmaceuticals, Ltd.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

MPWR vs. KNSA - Profitability Comparison

The chart below illustrates the profitability comparison between Monolithic Power Systems, Inc. and Kiniksa Pharmaceuticals, Ltd. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

MPWR - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Monolithic Power Systems, Inc. reported a gross profit of 541.07M and revenue of 980.64M. Therefore, the gross margin over that period was 55.2%.

KNSA - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Kiniksa Pharmaceuticals, Ltd. reported a gross profit of 220.03M and revenue of 243.60M. Therefore, the gross margin over that period was 90.3%.

MPWR - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Monolithic Power Systems, Inc. reported an operating income of 303.89M and revenue of 980.64M, resulting in an operating margin of 31.0%.

KNSA - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Kiniksa Pharmaceuticals, Ltd. reported an operating income of 27.19M and revenue of 243.60M, resulting in an operating margin of 11.2%.

MPWR - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Monolithic Power Systems, Inc. reported a net income of 257.30M and revenue of 980.64M, resulting in a net margin of 26.2%.

KNSA - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Kiniksa Pharmaceuticals, Ltd. reported a net income of 25.43M and revenue of 243.60M, resulting in a net margin of 10.4%.


Frequently Asked Questions


MPWR and KNSA have a correlation of 0.04, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

KNSA has higher volatility (26.47%) compared to MPWR (18.57%). In terms of maximum drawdown, MPWR dropped -72.27% vs KNSA's -83.06%.

KNSA currently has the higher Sharpe Ratio (2.94 vs 1.90), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for MPWR and KNSA

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer